Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
5.62
+0.13 (2.28%)
Mar 17, 2026, 4:00 PM EDT - Market closed
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $967.34 million as of March 17, 2026. Its market cap has increased by 69.42% in one year.
Market Cap
967.34M
Enterprise Value
1.11B
1-Year Change
69.42%
Ranking
Category
Stock Price
$5.62
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $967.34M, an increase of 227.05%. That is a compound annual growth rate of 30.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 946.65M | -27.32% |
| Dec 31, 2025 | 1.30B | 157.72% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
| Oct 6, 2021 | 295.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibrx Biosciences | 999.74M |
| Aktis Oncology | 997.40M |
| Pharming Group | 994.15M |
| uniQure | 971.08M |
| Compass Therapeutics | 934.66M |
| GH Research | 927.34M |
| Valneva SE | 911.69M |
| UroGen Pharma | 897.70M |